[Zaditen in the treatment of atopic bronchial asthma in adults]. 1985

J Ciszek, and A Kazimierczak, and P Krakówka

UI MeSH Term Description Entries
D007665 Ketotifen A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis. 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one,Ketotifen Fumarate,Ketotifene,Ketotiphen,Ketotiphene,Zaditen,Fumarate, Ketotifen
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

J Ciszek, and A Kazimierczak, and P Krakówka
October 1980, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J Ciszek, and A Kazimierczak, and P Krakówka
January 1982, Dakar medical,
J Ciszek, and A Kazimierczak, and P Krakówka
January 1984, Vutreshni bolesti,
J Ciszek, and A Kazimierczak, and P Krakówka
January 1983, Problemy medycyny wieku rozwojowego,
J Ciszek, and A Kazimierczak, and P Krakówka
January 1984, La Tunisie medicale,
J Ciszek, and A Kazimierczak, and P Krakówka
March 1980, Polskie Archiwum Medycyny Wewnetrznej,
J Ciszek, and A Kazimierczak, and P Krakówka
April 1981, Klinicheskaia meditsina,
J Ciszek, and A Kazimierczak, and P Krakówka
January 1986, Terapevticheskii arkhiv,
J Ciszek, and A Kazimierczak, and P Krakówka
September 1987, Praxis und Klinik der Pneumologie,
Copied contents to your clipboard!